Cat and mouse: The analytical toxicology of designer drugs

Bioanalysis

Volumn 3, Issue 3, 2011, Pages 249-251

  Elliott, Simon ^a  

^a Inverness Medical Innovations   (United States)

Author keywords

analytical toxicology; designer drugs; drug control; GC MS; LC MS

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 1 BENZYLPIPERAZINE DERIVATIVE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 METHOXYAMPHETAMINE; 4' METHYLMETHCATHINONE; AMPHETAMINE DERIVATIVE; DESIGNER DRUG; MEBEVERINE; METHAMPHETAMINE; PHENETHYLAMINE; SELEGILINE; TETRAHYDROGESTRINONE; TRAZODONE; TRYPTAMINE;

ANALYTIC METHOD; EDITORIAL; FOURIER TRANSFORM MASS SPECTROMETRY; HUMAN; INFRARED SPECTROMETRY; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; QUADRUPOLE MASS SPECTROMETRY; QUALITATIVE ANALYSIS; RAMAN SPECTROMETRY; SENSITIVITY ANALYSIS; TOXICOLOGY;

CHEMISTRY TECHNIQUES, ANALYTICAL; DESIGNER DRUGS;

EID: 79951764729     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.10.206     Document Type: Editorial

References (9)

1. King LA. In:The Misuse of Drugs Act: A Guide for Forensic Scientists. (Ed.). Royal Society of Chemistry Paperbacks, London, UK (2003).
2. Wohlfarth A, Weinmann W. Bioanalysis of new designer drugs. Bioanalysis 2(5), 965-979 (2010).
3. Peters FT, Schaefer S, Staack RF, Kraemer T, Maurer HH. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography-mass spectrometry. J. Mass Spec. 38, 659-676 (2003). (Pubitemid 36818224)
4. Brandt SD, Sumnall HR, Measham F, Cole J. Analyses of second-generation legal highs in the UK: initial findings. Drug Test Anal. 2(8), 377-382 (2010).
5. Winstock A, Mitcheson L, Marsden J. Mephedrone: still available and twice the price. Lancet 376(9752), 1537 (2010).
6. Nutt DJ, King LA, Phillips LD. Independent scientific committee on drugs. Drug harms in the UK: a multicriteria decision analysis. Lancet 376(9752), 1558-1565 (2010).
7. Elliott S, Smith C. Investigation of the first deaths in the UK involving the detection and quantitation of the piperazines BZP and 3-TFMPP. J. Anal. Toxicol. 32(2), 172-177 (2008). (Pubitemid 351362752)
8. Ojanperä L, Pelander A, Laks S, Gergov M, Vuori E, Witt M. Application of accurate mass measurement to urine drug screening. J. Anal. Toxicol. 29(1), 34-40 (2005). (Pubitemid 40128943)
9. Maurer HH. Chemistry, pharmacology, and metabolism of emerging drugs of abuse. Ther. Drug Monit. 32(5), 544-549 (2010).